Sobi anticipates 2015 sales increase

Country

Sweden

Swedish Orphan Biovitrum AB (Sobi), which specialises in treatments for rare diseases, reported a 19.8% increase in revenue in 2014 but its loss widened sharply, mainly because of a write-off connected with a product failure.